0

Close
 
Upcoming Allied Market Research
2023
Liver-on-chip Market

Liver-on-Chip Market

by Type (Liver-on-a-chip, Kidney-on-a-chip, Lung-on-a-chip, Heart-on-a-chip, Intestine-on-a-chip, Brain-on-a-chip, Other Organs.) and by Application (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Cosmetics Industry, Other End Users): Global Opportunity Analysis and Industry Forecast, 2023-2032

SE : Emerging and Next Generation Technologies
Report Code: A04613
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: LIVER-ON-CHIP MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. Liver-on-a-chip

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Kidney-on-a-chip

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Lung-on-a-chip

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Heart-on-a-chip

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Intestine-on-a-chip

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

    • 4.7. Brain-on-a-chip

      • 4.7.1. Key Market Trends, Growth Factors and Opportunities

      • 4.7.2. Market Size and Forecast, By Region

      • 4.7.3. Market Share Analysis, By Country

    • 4.8. Other Organs.

      • 4.8.1. Key Market Trends, Growth Factors and Opportunities

      • 4.8.2. Market Size and Forecast, By Region

      • 4.8.3. Market Share Analysis, By Country

  • CHAPTER 5: LIVER-ON-CHIP MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Pharmaceutical And Biotechnology Companies

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Academic And Research Institutes

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Cosmetics Industry

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Other End Users

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

  • CHAPTER 6: LIVER-ON-CHIP MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Type

      • 6.2.3. Market Size and Forecast, By Application

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Liver-on-chip Market

        • 6.2.5.1. Market Size and Forecast, By Type
        • 6.2.5.2. Market Size and Forecast, By Application

      • 6.2.6. Canada Liver-on-chip Market

        • 6.2.6.1. Market Size and Forecast, By Type
        • 6.2.6.2. Market Size and Forecast, By Application

      • 6.2.7. Mexico Liver-on-chip Market

        • 6.2.7.1. Market Size and Forecast, By Type
        • 6.2.7.2. Market Size and Forecast, By Application

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Type

      • 6.3.3. Market Size and Forecast, By Application

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Liver-on-chip Market

        • 6.3.5.1. Market Size and Forecast, By Type
        • 6.3.5.2. Market Size and Forecast, By Application

      • 6.3.6. Germany Liver-on-chip Market

        • 6.3.6.1. Market Size and Forecast, By Type
        • 6.3.6.2. Market Size and Forecast, By Application

      • 6.3.7. Italy Liver-on-chip Market

        • 6.3.7.1. Market Size and Forecast, By Type
        • 6.3.7.2. Market Size and Forecast, By Application

      • 6.3.8. Spain Liver-on-chip Market

        • 6.3.8.1. Market Size and Forecast, By Type
        • 6.3.8.2. Market Size and Forecast, By Application

      • 6.3.9. UK Liver-on-chip Market

        • 6.3.9.1. Market Size and Forecast, By Type
        • 6.3.9.2. Market Size and Forecast, By Application

      • 6.3.10. Russia Liver-on-chip Market

        • 6.3.10.1. Market Size and Forecast, By Type
        • 6.3.10.2. Market Size and Forecast, By Application

      • 6.3.11. Rest Of Europe Liver-on-chip Market

        • 6.3.11.1. Market Size and Forecast, By Type
        • 6.3.11.2. Market Size and Forecast, By Application

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Type

      • 6.4.3. Market Size and Forecast, By Application

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Liver-on-chip Market

        • 6.4.5.1. Market Size and Forecast, By Type
        • 6.4.5.2. Market Size and Forecast, By Application

      • 6.4.6. Japan Liver-on-chip Market

        • 6.4.6.1. Market Size and Forecast, By Type
        • 6.4.6.2. Market Size and Forecast, By Application

      • 6.4.7. India Liver-on-chip Market

        • 6.4.7.1. Market Size and Forecast, By Type
        • 6.4.7.2. Market Size and Forecast, By Application

      • 6.4.8. South Korea Liver-on-chip Market

        • 6.4.8.1. Market Size and Forecast, By Type
        • 6.4.8.2. Market Size and Forecast, By Application

      • 6.4.9. Australia Liver-on-chip Market

        • 6.4.9.1. Market Size and Forecast, By Type
        • 6.4.9.2. Market Size and Forecast, By Application

      • 6.4.10. Thailand Liver-on-chip Market

        • 6.4.10.1. Market Size and Forecast, By Type
        • 6.4.10.2. Market Size and Forecast, By Application

      • 6.4.11. Malaysia Liver-on-chip Market

        • 6.4.11.1. Market Size and Forecast, By Type
        • 6.4.11.2. Market Size and Forecast, By Application

      • 6.4.12. Indonesia Liver-on-chip Market

        • 6.4.12.1. Market Size and Forecast, By Type
        • 6.4.12.2. Market Size and Forecast, By Application

      • 6.4.13. Rest of Asia Pacific Liver-on-chip Market

        • 6.4.13.1. Market Size and Forecast, By Type
        • 6.4.13.2. Market Size and Forecast, By Application

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Type

      • 6.5.3. Market Size and Forecast, By Application

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Liver-on-chip Market

        • 6.5.5.1. Market Size and Forecast, By Type
        • 6.5.5.2. Market Size and Forecast, By Application

      • 6.5.6. South Africa Liver-on-chip Market

        • 6.5.6.1. Market Size and Forecast, By Type
        • 6.5.6.2. Market Size and Forecast, By Application

      • 6.5.7. Saudi Arabia Liver-on-chip Market

        • 6.5.7.1. Market Size and Forecast, By Type
        • 6.5.7.2. Market Size and Forecast, By Application

      • 6.5.8. UAE Liver-on-chip Market

        • 6.5.8.1. Market Size and Forecast, By Type
        • 6.5.8.2. Market Size and Forecast, By Application

      • 6.5.9. Argentina Liver-on-chip Market

        • 6.5.9.1. Market Size and Forecast, By Type
        • 6.5.9.2. Market Size and Forecast, By Application

      • 6.5.10. Rest of LAMEA Liver-on-chip Market

        • 6.5.10.1. Market Size and Forecast, By Type
        • 6.5.10.2. Market Size and Forecast, By Application

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning,2022

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Emulate

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. TissUse

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Hesperos

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. CN Bio Innovations

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Tara Biosystems

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Draper Laboratory

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Mimetas

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Nortis

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Micronit Microtechnologies B.V.

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Kirkstall

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL LIVER-ON-CHIP MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL LIVER-ON-CHIP MARKET FOR LIVER-ON-A-CHIP, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL LIVER-ON-CHIP MARKET FOR KIDNEY-ON-A-CHIP, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL LIVER-ON-CHIP MARKET FOR LUNG-ON-A-CHIP, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL LIVER-ON-CHIP MARKET FOR HEART-ON-A-CHIP, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL LIVER-ON-CHIP MARKET FOR INTESTINE-ON-A-CHIP, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL LIVER-ON-CHIP MARKET FOR BRAIN-ON-A-CHIP, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL LIVER-ON-CHIP MARKET FOR OTHER ORGANS., BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL LIVER-ON-CHIP MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL LIVER-ON-CHIP MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL LIVER-ON-CHIP MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL LIVER-ON-CHIP MARKET FOR COSMETICS INDUSTRY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL LIVER-ON-CHIP MARKET FOR OTHER END USERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL LIVER-ON-CHIP MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. NORTH AMERICA LIVER-ON-CHIP, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. NORTH AMERICA LIVER-ON-CHIP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 17. NORTH AMERICA LIVER-ON-CHIP, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 18. U.S. LIVER-ON-CHIP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 19. U.S. LIVER-ON-CHIP, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 20. CANADA LIVER-ON-CHIP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 21. CANADA LIVER-ON-CHIP, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 22. MEXICO LIVER-ON-CHIP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 23. MEXICO LIVER-ON-CHIP, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 24. EUROPE LIVER-ON-CHIP, BY REGION, 2022-2032 ($MILLION)
  • TABLE 25. EUROPE LIVER-ON-CHIP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 26. EUROPE LIVER-ON-CHIP, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 27. FRANCE LIVER-ON-CHIP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 28. FRANCE LIVER-ON-CHIP, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 29. GERMANY LIVER-ON-CHIP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 30. GERMANY LIVER-ON-CHIP, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 31. ITALY LIVER-ON-CHIP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 32. ITALY LIVER-ON-CHIP, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 33. SPAIN LIVER-ON-CHIP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 34. SPAIN LIVER-ON-CHIP, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 35. UK LIVER-ON-CHIP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 36. UK LIVER-ON-CHIP, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 37. RUSSIA LIVER-ON-CHIP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 38. RUSSIA LIVER-ON-CHIP, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 39. REST OF EUROPE LIVER-ON-CHIP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 40. REST OF EUROPE LIVER-ON-CHIP, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 41. ASIA-PACIFIC LIVER-ON-CHIP, BY REGION, 2022-2032 ($MILLION)
  • TABLE 42. ASIA-PACIFIC LIVER-ON-CHIP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 43. ASIA-PACIFIC LIVER-ON-CHIP, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 44. CHINA LIVER-ON-CHIP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 45. CHINA LIVER-ON-CHIP, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 46. JAPAN LIVER-ON-CHIP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 47. JAPAN LIVER-ON-CHIP, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 48. INDIA LIVER-ON-CHIP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 49. INDIA LIVER-ON-CHIP, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 50. SOUTH KOREA LIVER-ON-CHIP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 51. SOUTH KOREA LIVER-ON-CHIP, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 52. AUSTRALIA LIVER-ON-CHIP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 53. AUSTRALIA LIVER-ON-CHIP, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 54. THAILAND LIVER-ON-CHIP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 55. THAILAND LIVER-ON-CHIP, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 56. MALAYSIA LIVER-ON-CHIP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 57. MALAYSIA LIVER-ON-CHIP, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 58. INDONESIA LIVER-ON-CHIP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 59. INDONESIA LIVER-ON-CHIP, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 60. REST OF ASIA PACIFIC LIVER-ON-CHIP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 61. REST OF ASIA PACIFIC LIVER-ON-CHIP, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 62. LAMEA LIVER-ON-CHIP, BY REGION, 2022-2032 ($MILLION)
  • TABLE 63. LAMEA LIVER-ON-CHIP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 64. LAMEA LIVER-ON-CHIP, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 65. BRAZIL LIVER-ON-CHIP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 66. BRAZIL LIVER-ON-CHIP, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 67. SOUTH AFRICA LIVER-ON-CHIP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 68. SOUTH AFRICA LIVER-ON-CHIP, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 69. SAUDI ARABIA LIVER-ON-CHIP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 70. SAUDI ARABIA LIVER-ON-CHIP, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 71. UAE LIVER-ON-CHIP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 72. UAE LIVER-ON-CHIP, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 73. ARGENTINA LIVER-ON-CHIP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 74. ARGENTINA LIVER-ON-CHIP, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 75. REST OF LAMEA LIVER-ON-CHIP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 76. REST OF LAMEA LIVER-ON-CHIP, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 77. EMULATE: KEY EXECUTIVES
  • TABLE 78. EMULATE: COMPANY SNAPSHOT
  • TABLE 79. EMULATE: OPERATING SEGMENTS
  • TABLE 80. EMULATE: PRODUCT PORTFOLIO
  • TABLE 81. EMULATE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 82. TISSUSE: KEY EXECUTIVES
  • TABLE 83. TISSUSE: COMPANY SNAPSHOT
  • TABLE 84. TISSUSE: OPERATING SEGMENTS
  • TABLE 85. TISSUSE: PRODUCT PORTFOLIO
  • TABLE 86. TISSUSE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 87. HESPEROS: KEY EXECUTIVES
  • TABLE 88. HESPEROS: COMPANY SNAPSHOT
  • TABLE 89. HESPEROS: OPERATING SEGMENTS
  • TABLE 90. HESPEROS: PRODUCT PORTFOLIO
  • TABLE 91. HESPEROS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 92. CN BIO INNOVATIONS: KEY EXECUTIVES
  • TABLE 93. CN BIO INNOVATIONS: COMPANY SNAPSHOT
  • TABLE 94. CN BIO INNOVATIONS: OPERATING SEGMENTS
  • TABLE 95. CN BIO INNOVATIONS: PRODUCT PORTFOLIO
  • TABLE 96. CN BIO INNOVATIONS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 97. TARA BIOSYSTEMS: KEY EXECUTIVES
  • TABLE 98. TARA BIOSYSTEMS: COMPANY SNAPSHOT
  • TABLE 99. TARA BIOSYSTEMS: OPERATING SEGMENTS
  • TABLE 100. TARA BIOSYSTEMS: PRODUCT PORTFOLIO
  • TABLE 101. TARA BIOSYSTEMS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 102. DRAPER LABORATORY: KEY EXECUTIVES
  • TABLE 103. DRAPER LABORATORY: COMPANY SNAPSHOT
  • TABLE 104. DRAPER LABORATORY: OPERATING SEGMENTS
  • TABLE 105. DRAPER LABORATORY: PRODUCT PORTFOLIO
  • TABLE 106. DRAPER LABORATORY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 107. MIMETAS: KEY EXECUTIVES
  • TABLE 108. MIMETAS: COMPANY SNAPSHOT
  • TABLE 109. MIMETAS: OPERATING SEGMENTS
  • TABLE 110. MIMETAS: PRODUCT PORTFOLIO
  • TABLE 111. MIMETAS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 112. NORTIS: KEY EXECUTIVES
  • TABLE 113. NORTIS: COMPANY SNAPSHOT
  • TABLE 114. NORTIS: OPERATING SEGMENTS
  • TABLE 115. NORTIS: PRODUCT PORTFOLIO
  • TABLE 116. NORTIS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 117. MICRONIT MICROTECHNOLOGIES B.V.: KEY EXECUTIVES
  • TABLE 118. MICRONIT MICROTECHNOLOGIES B.V.: COMPANY SNAPSHOT
  • TABLE 119. MICRONIT MICROTECHNOLOGIES B.V.: OPERATING SEGMENTS
  • TABLE 120. MICRONIT MICROTECHNOLOGIES B.V.: PRODUCT PORTFOLIO
  • TABLE 121. MICRONIT MICROTECHNOLOGIES B.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 122. KIRKSTALL: KEY EXECUTIVES
  • TABLE 123. KIRKSTALL: COMPANY SNAPSHOT
  • TABLE 124. KIRKSTALL: OPERATING SEGMENTS
  • TABLE 125. KIRKSTALL: PRODUCT PORTFOLIO
  • TABLE 126. KIRKSTALL: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL LIVER-ON-CHIP MARKET SEGMENTATION
  • FIGURE 2. GLOBAL LIVER-ON-CHIP MARKET
  • FIGURE 3. SEGMENTATION LIVER-ON-CHIP MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN LIVER-ON-CHIP MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALLIVER-ON-CHIP MARKET
  • FIGURE 11. LIVER-ON-CHIP MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 12. LIVER-ON-CHIP MARKET FOR LIVER-ON-A-CHIP, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. LIVER-ON-CHIP MARKET FOR KIDNEY-ON-A-CHIP, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. LIVER-ON-CHIP MARKET FOR LUNG-ON-A-CHIP, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. LIVER-ON-CHIP MARKET FOR HEART-ON-A-CHIP, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. LIVER-ON-CHIP MARKET FOR INTESTINE-ON-A-CHIP, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. LIVER-ON-CHIP MARKET FOR BRAIN-ON-A-CHIP, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. LIVER-ON-CHIP MARKET FOR OTHER ORGANS., BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. LIVER-ON-CHIP MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 20. LIVER-ON-CHIP MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. LIVER-ON-CHIP MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. LIVER-ON-CHIP MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. LIVER-ON-CHIP MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 24. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 25. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 26. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 27. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 28. COMPETITIVE DASHBOARD
  • FIGURE 29. COMPETITIVE HEATMAP: LIVER-ON-CHIP MARKET
  • FIGURE 30. Top player positioning, 2022
  • FIGURE 31. EMULATE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 32. EMULATE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 33. EMULATE: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 34. TISSUSE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 35. TISSUSE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 36. TISSUSE: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 37. HESPEROS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 38. HESPEROS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 39. HESPEROS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 40. CN BIO INNOVATIONS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 41. CN BIO INNOVATIONS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 42. CN BIO INNOVATIONS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 43. TARA BIOSYSTEMS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 44. TARA BIOSYSTEMS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 45. TARA BIOSYSTEMS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 46. DRAPER LABORATORY: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 47. DRAPER LABORATORY: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 48. DRAPER LABORATORY: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 49. MIMETAS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 50. MIMETAS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 51. MIMETAS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 52. NORTIS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 53. NORTIS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 54. NORTIS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 55. MICRONIT MICROTECHNOLOGIES B.V.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 56. MICRONIT MICROTECHNOLOGIES B.V.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 57. MICRONIT MICROTECHNOLOGIES B.V.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 58. KIRKSTALL: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 59. KIRKSTALL: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 60. KIRKSTALL: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Liver-on-chip Market

Start reading.
This Report and over 66,905+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers